background preloader

Innovative Medical Devices

Facebook Twitter

Future Meters & Monitors. The following links explore new methods in non-invasive, semi-invasive, and subcutaneous, measuring of blood glucose.

Future Meters & Monitors

We will examine the research behind these new technologies, how each new technique works, FDA status, and the companies involved with the funding of each project. Monitors Glysens GlySens Incorporated is a privately held corporation located in San Diego, California that's been around since 1998. Their focus is on an implantable long term continuous glucose monitoring sensor that will help people with diabetes monitor their glucose levels accurately without the usual fingersticks. Hypomon by AIMedics AiMedics, established in October 2001 as a commercial spin-off of the University of Technology, Sydney (UTS), specializes in non-invasive monitoring for various diseases, including diabetes, epilepsy, fatigue and Sudden Infant Death Syndrome.

The Glucoday S by A.Menarini Diagnostics Photonic Glucose Sensor by Onsens Scout DS by VeraLight Lightouch Medical Optiscan Orsense Senseonics. Oticon Medical receives FDA clearance to market new Ponto Plus family of bone anchored sound processors. eNeura - eNeura. Www.americanheadachesociety.org/assets/1/7/Migraine_Aura_July-August_2009.pdf.

Welcome to Alere - Health Diagnostic Products & Services. Alere INRatio PT/INR Monitoring System - Home. Technology. The Gema Kit Our patient-issued Gema Kit, combines patent-pending hardware, off the shelf mobile capabilites linked to a patient-centric website, in order to connect day-to-day actions (such as taking pills) to a cloud-based tracking and engagement software system.

Technology

The Gema Kit includes: Dual NFC and bar code/quick response coded "patches" of various sizes that the patient adheres to the outside of their pill bottles and packs Links to a free engagement website Back-end data tracking and reporting service for providers Each patch within the kit is paper thin. Through proximity of a user's mobile device, the patch enables an instantly to a web-based patient system that will: Enable logging of NIH PROMIS guided, quality of life measures at the point of care, as well as Connecting patient's to other stakeholders that are important them and to their fight.

Gema Patches Data Tracking. AMS Receives FDA Approval for Surgical System to Treat Female Stress Urinary Incontinence. 0inShare American Medical Systems (Minneapolis, MN) has received FDA 510(k) clearance for the RetroArc Retropubic Sling System for treatment of female stress urinary incontinence (SUI).

AMS Receives FDA Approval for Surgical System to Treat Female Stress Urinary Incontinence

SUI, which affects about 13 million women in the US, causes involuntary loss of urine during coughing, laughing, or sneezing. This is certainly embarrassing and unpleasant for patients. The RetroArc is a minimally invasive transvaginal retropubic sling system that can be used to treat SUI through an outpatient procedure. It consists of two 4mm diameter needles that provide flexural rigidity as they’re advances through the vaginal cavity. The RetroArc procedure is performed by first inserting the two curved needles into the peri-urethral tunnel, such that they make contact with the posterior surface of the pubic bone, and then having them exit through a suprapubic incision. Here’s an animation showing the implantation of the RetroArc: Product page: The RetroArc Retropubic Sling System…

Medical. It Just Works Regardless of whether you have 5 users or 50,000, we've got you covered.

Medical

Simplicity It doesn't distract you with configuration issues and technical problems requiring constant support. Our scale works right out of the box, requires no user configuration and data is delivered to you immediately. Reliablility Our scale and monitoring system allows you to focus on your mission, be that scientific research or helping people manage their weight. FDA Approves Kerecis’s Fish Skin Technology to Heal Wounds. 7inShare Kerecis Limited (Reykjavik, Iceland) has received FDA approval for the fish skin-based MariGen Omega3 tissue-regeneration technology approved for use to treat chronic wounds due to diabetes or other circulatory problems.

FDA Approves Kerecis’s Fish Skin Technology to Heal Wounds

MariGen Omega3 products are decellularized fish skin sheets that have had cells and antigenic materials extracted. These fish skin sheets are similar to human skin, except that they contain Omega3 polyunsaturated fatty acids that are thought to promote wound healing along with other health benefits. According to company’s press release, each year close to 6 million people in the US suffer from chronic wounds due to diabetes or other circulatory problems, and delayed healing of these wounds can lead to severe consequences such as amputation or even death. Chronic wounds unlike regular wounds do not follow the normal wound healing process of inflammation followed by proliferation followed by remodeling. Product page: Chronic wound treatment with MariGen Wound…